Inside Trading

     SEATTLE – Seattle Genetics manager Zizhong Fan tipped relatives to inside information about good results for a cancer drug in clinical trials, and the Fans made more than $803,000 by illegally trading on the tip, the SEC claims in Federal Court; it sued only the Fans, not the company.

%d bloggers like this: